These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Hypertension therapy for type 2 diabetics]. Bönner G MMW Fortschr Med; 2007 Jun; 149(23):45, 47-8. PubMed ID: 18062579 [No Abstract] [Full Text] [Related]
6. ARBs vs. ACE inhibitors: which is better for hypertension? ACE inhibitors are generally preferable, but ARBs offer an effective alternative for patients suffering side effects. Heart Advis; 2008 Jul; 11(7):4. PubMed ID: 18763362 [No Abstract] [Full Text] [Related]
7. [Telmisartan (micardis) -- an antagonist of angiotensin 2 of type 1 receptors: another antihypertensive drug or something greater?]. Chazova IE Ter Arkh; 2003; 75(6):89-91. PubMed ID: 12920969 [No Abstract] [Full Text] [Related]
8. Blood pressure reduction is not the only determinant of outcome. Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR; Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR Circulation; 2006 Jun; 113(23):2754-72; discussion 2773-4. PubMed ID: 16769926 [No Abstract] [Full Text] [Related]
10. Renin inhibition: what are the clinical perspectives? Hollenberg NK Semin Nephrol; 2007 Sep; 27(5):511-8. PubMed ID: 17868787 [TBL] [Abstract][Full Text] [Related]
11. More is less? Optimal combination therapy for adequate blood pressure lowering in hypertension. Kjeldsen SE; Hedner T; Narkiewicz K; Oparil S Blood Press; 2008; 17(3):132-3. PubMed ID: 18665471 [No Abstract] [Full Text] [Related]
12. ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading? Oparil S; Kjeldsen SE; Hedner T; Narkiewicz K Blood Press; 2009; 18(1-2):4-6. PubMed ID: 19191085 [No Abstract] [Full Text] [Related]
13. Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy. Tempelhof MW South Med J; 2009 Dec; 102(12):1201-2. PubMed ID: 20016423 [No Abstract] [Full Text] [Related]
14. [Renoprotective effect of Blood pressure control on progression of diabetic retinopathies]. Katayama S Nihon Rinsho; 2005 Jun; 63 Suppl 6():389-93. PubMed ID: 15999740 [No Abstract] [Full Text] [Related]
15. Are two better than one? Angiotensin-converting enzyme inhibitors plus angiotensin receptor blockers for reducing blood pressure and proteinuria in kidney disease. Linas SL Clin J Am Soc Nephrol; 2008 Jan; 3 Suppl 1(Suppl 1):S17-23. PubMed ID: 18178792 [TBL] [Abstract][Full Text] [Related]
17. The renin system: is direct renin inhibition different from blockade at the AT1 receptor or the ACE step? Hollenberg NK Rev Cardiovasc Med; 2007; 8 Suppl 2():S7-13. PubMed ID: 17401314 [TBL] [Abstract][Full Text] [Related]
18. Preventing complications in diabetic patients: blood pressure control essential. Golden W; Kinggard T; Potts SG J Ark Med Soc; 2006 Sep; 103(3):58-9. PubMed ID: 16986761 [No Abstract] [Full Text] [Related]
19. Management of hypertension in patients with chronic kidney disease and diabetes mellitus. Palmer BF Am J Med; 2008 Aug; 121(8 Suppl):S16-22. PubMed ID: 18638614 [TBL] [Abstract][Full Text] [Related]
20. Benefits and risks of combination therapy in hypertension. Node K Hypertens Res; 2009 Sep; 32(9):727-8. PubMed ID: 19609269 [No Abstract] [Full Text] [Related] [Next] [New Search]